920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant RecipientsC Boutin, Robin K. Avery, Michael D. Green et al.|American Journal of Transplantation|2023Cited by 2